To move an industry forward, you need fresh thinking and bold doing.
To move an industry forward, you need fresh thinking and bold doing.
About Podtech™
Public health emergencies such as pandemics, highly contagious disease outbreaks, or geopolitical disruptions rarely come with a warning label. Governments and pharmaceutical companies must be prepared to respond swiftly, flexibly, and at scale, often under intense time pressure and operational constraints.
Podtech™ was developed to address this critical need. It is a cost-effective, time-efficient, start-to-finish modular solution for rapidly scalable biopharmaceutical development and manufacturing, enabling organizations to build, expand, or repurpose production capacity without the delays of conventional facilities.
Read More
Each Podtech™ unit comprises a configurable cluster of single or multiple podules™, engineered for reliability in demanding environments. Every podule™ is all-weather proof, seismically designed, and constructed using a reinforced steel structure with modular prefab architecture and industrial-grade vinyl flooring, ensuring durability, safety, and operational consistency.
Built entirely offsite, Podtech™ units are delivered fully assembled, prevalidated, and plug-and-play, significantly reducing on-site construction time, project risk, and disruption. Customizable configurations allow facilities to be tailored precisely to process, capacity, and regulatory requirements.
Whether supporting established pharmaceutical manufacturers scaling for specific programs or startups launching operations, Podtech™ enables rapid build, scale-up, and scale-out. Optional technology licensing and global manufacturing collaborations support accelerated go-to-market for applications such as fill-and-finish facilities, inhalation suites, oncology manufacturing, and novel therapeutic products.
Designed with repurposability and sustainability at its core, Podtech™ can be adapted to evolving use cases over time, helping organizations optimize capital investment, reduce environmental impact, and meet long-term sustainability and resilience goals efficiently.
PodTech TM accelerates crisis manufacturing capability
We're on a mission to future-proof the world against the next health crisis
COVID-19 exposed the faultlines in our health systems and showed us how unprepared we are. Millions have died needlessly. Health systems continue to grapple with the continuing health impacts of Covid-19. The aftermath has proliferated a number of serious health conditions - brain fog, strokes, diabetes, kidney and heart disease - that are mini epidemics in themselves.
Wealthy countries can look after their own. Low and middle-income countries, reliant on medicine imports, are left to fend for themselves.
Stronger local production means more equitable access to lifesaving care.
With PodTech, governments and enterprising entrepreneurs alike can build your own path to regional self-sufficiency, especially in regions that have never had a seat at the table. You can better respond to public health emergencies.
PodTech™️ inoculates nations against health calamities.
The people behind the podule™️
Building regional pharmaceutical and biotech manufacturing capability is not child’s play.
It should be.
PodTech™️ is the latest initiative from Aasif Ahsan Khan of the Fabtech group. For over two decades, Fabtech has been one of the leading providers of start-to-finish solutions for biopharma companies across the world, from projects to essential equipment for air, water and process applications.
Fabtech builds manufacturing capability all over the world – through pharmaceutical projects and an essential equipment manufacturing ecosystem for pharmaceutical and biopharmaceutical companies. Each new project we take on means we can reshape the world into a more equitable place for everyone.
Fabtech is making medicines affordable and accessible everywhere. PodTech™️ is accelerating this mission in geographies that need speed.